Buprenorphine Tablet
Product Images NDC 71335-3152

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 71335-3152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-figure (Buprenorphine Figure)

FDA Label Image

Buprenorphine-str (Buprenorphine Str)

FDA Label Image

Label (Lbl713353152)

Label (Lbl713353152)
This description is about a medication containing 8.64 mg Buprenorphine HCI in each sublingual tablet, equivalent to 8 mg of Buprenorphine. It is recommended to store the tablets at 20° to 25°C (68° to 77°F) and dispense them in a light-resistant container with a child-resistant closure. The usual dosage information can be found in the package insert QR code. It is advised that the pharmacist provides the Medication Guide to each patient. In case of accidental ingestion by a child, emergency medical care is required, so keeping the medication out of the reach of children is crucial.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.